Extremely low frequency electromagnetic fields affect proliferation and mitochondrial activity of human cancer cell

Michele Destefanis1, Marta Viano1, Christian Leo2

  • 1a Department of Oncology , University of Torino , Torino , Italy ;

Abstract

Insights

Extremely low frequency electromagnetic fields (ELF-EMF) exposure reduced cancer cell growth by increasing mitochondrial activity and altering protein expression, suggesting a novel therapeutic avenue for cancer treatment.

Area of Science:

  • Biophysics
  • Cell Biology
  • Cancer Research

Background:

  • Mitochondrial metabolism's role in cancer is critical.
  • The impact of electromagnetic fields on cell metabolism remains largely unexplored.
  • Extremely low frequency electromagnetic fields (ELF-EMF) may influence cellular processes.

Purpose of the Study:

  • To investigate the effects of ELF-EMF on mitochondrial metabolism.
  • To determine the impact of ELF-EMF on cancer cell proliferation.
  • To elucidate the relationship between ELF-EMF, mitochondrial function, and cancer growth.

Main Methods:

  • Human cancer cell lines were exposed to ELF-EMF.
  • Cell proliferation was assessed using crystal violet assay.
  • Mitochondrial activity was evaluated via membrane potential and transcription analysis.
  • Mitochondrial protein expression was quantified.

Main Results:

  • Long-term ELF-EMF exposure inhibited proliferation in multiple cancer cell lines.
  • Mitochondrial activity increased with ELF-EMF exposure, without significant ATP level changes.
  • Transcriptional modulation of respiratory complexes was ruled out; increased energy demand was suggested.
  • Altered mitochondrial metabolism resulted in changes to protein profiles, including downregulation of phospho-ERK, p53, and cytochrome c.

Conclusions:

  • ELF-EMF exposure negatively modulates cancer cell growth.
  • Increased cellular respiratory activity and altered mitochondrial protein expression are key effects.
  • ELF-EMF influences cancer cell metabolism and proliferation through mitochondrial pathways.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.5K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K